This is the first article in a series investigating the Church of Psilomethoxin (CoP), exploring the recent debate about the Church's sacrament and the...
Cybin Inc. (NEO:CYBN / NYSE American:CYBN) a clinical-stage biopharmaceutical company committed to revolutionizing mental healthcare by developing new...
Executive Director William Garner now owns or exercises control over nearly 40% of common shares. The post Tryp Therapeutics Raises AUD$2.4 Million appeared...
Breaking Convention in Exeter is the indie label equivalent to the corporadelic mega conventions taking over across the psychedelic realm, with equal emphasis...
The article Microdosing LSD: Exploring Sub-Perceptual Doses was originally published on Microdose. In recent years, the practice of microdosing LSD (and...
Initially, only psilocybin and psilocyn would be allowed at therapeutic centers. The post Colorado Senate Bill Paves Way for Licensed Therapeutic Centers...
The compounds have shown positive results in pre-clinical studies. The post Mindset Pharma Files Patents for Nonhallucinogenic Psychedelic Drugs to Treat...
Silo's CEO wants to steer Oregon psilocybin operators away from a "dangerous cash-only system." The post Silo Wellness Looks to Crypto for Psilocybin Payment...
The article Mydecine Reports Positive Preclinical Results on MYCO-006 Short-Acting MDMA Analogues was originally published on Microdose. Mydecine Reports...
Is microdosing right for you? Discover the benefits of microdosing shrooms and learn how to craft your microdosing routine.